Shandong Xinhua Pharmaceutical Co (FRA:XIN) Net Interest Margin (Bank Only) %


FRA:XIN Shandong Xinhua Pharmaceutical Co Ltd FRA:XIN
53 GF Score
Price €0.64
GF Value €0.81
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shandong Xinhua Pharmaceutical Co Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:XIN
53GF Score
Shandong Xinhua Pharmaceutical Co Ltd FRA:XIN
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shandong Xinhua Pharmaceutical Co (FRA:XIN) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co stock appears to be undervalued. The current stock price of €0.64 is trading 21.6% below its estimated GF Value™ of €0.81. GuruFocus considers Shandong Xinhua Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for FRA:XIN:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €0.81 vs. price of €0.64 (21.6% below fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the FRA:XIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Xinhua Pharmaceutical Co Business Description

Other Exchanges 00719:Hong Kong000756:China
Address No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.
53GF Score

Get the complete analysis for FRA:XIN

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.64
Price
€0.81
GF Value